We have developed an anion-exchange high-performance liquid chromatography (HPLC) method using Q Sepharose XL (Amersham Pharmacia Biotech) as adsorbent to analyze samples containing adenovirus. This method has several major advantages over the HPLC method previously described for quantitating particles, namely (1) a Ͼ10-fold improvement in the detection limit of adenovirus in crude preparations; (2) absence of interferences originating from nucleic acids and proteins which usually contaminate crude samples; (3) unprecedented sharpness and symmetry of adenovirus peak, rendering the identification of the viral peak unambiguous, even in extremely crude and dilute prep-
Introduction
A large number of gene therapy clinical trials utilize recombinant adenoviruses as vectors for gene tranfer into humans. The development of manufacturing processes for adenovirus requires that accurate, rapid, and sensitive methods be developed to assay particles at all stages of the production process. Until recently, the method currently used to quantitate particles in adenovirus preparations was an anion-exchange HPLC method on Source 15Q. 1, 2 The development and availability of an HPLC method for assaying particles in crude preparations represented an important achievement, allowing for the first time fast and accurate quantitation of particles in preparations. Only semi-quantitative and time-consuming biological assays have been available previously. 3 Despite this major progress, this method suffers from some severe limitations, including (1) insufficient sensitivity precluding particle quantitation in transfections and in very dilute preparations; (2) interferences with proteins in some production media, and with host nucleic acids; and (3) difficulties in identifying unambiguously the adenovirus peak in very complex mixtures. This study was undertaken to develop an HPLC method which ideally would overcome these limitations. This report summarizes our results and describes a new method, its performance and applications. arations; and (4) no enzymatic treatment required even for crude samples. This assay was used to quantitate particles in samples taken at the transfection and amplification stages of production of various recombinant adenovirus, and in cultures of wild-type adenovirus of different serotypes. A modification of this analytical method was also developed for the purification of infectious adenovirus particles, including fibermodified and third-generation recombinant viruses, giving highly purified preparations from low-titer crude lysates with an excellent overall recovery (50-74%). Gene Therapy (2000) 7, 1055-1062.
Results

Column performances
In the course of this study, a number of anion-exchange adsorbents for chromatography were evaluated for their performances with adenovirus particles. As demonstrated below, Q Sepharose XL was finally selected owing to its excellent and unsurpassed separation performances. The chromatographic performance of Q Sepharose XL were obtained from analyses of 2.0 × 10 10 purified particles on a 1 ml HR 5/5 column. Both column efficiency (N/m) and peak asymmetry (As) were very good (35 000 ± 3000 and 1.05 ± 0.05, respectively) and significantly better than with other matrices tested (Table 1) , including Source 15Q (N/m, 21 000 ± 2400 ; As, 1.4 ± 0.2). The adenovirus peak was very sharp and highly symmetrical for both purified material ( Figure 1 ) and crude lysates (Figure 2 ), both types of samples giving identical chromatographic performances for adenovirus particles.
In contrast, the performance of Q Sepharose XL for proteins was very modest, giving very broad peaks (eg N/m, 600 for albumin, Figure 3 ) which were therefore easily distinguishable from the virus peak (Figures 2 and  3) . As a result, the shape of the viral peak can constitute a key parameter for the identification of the adenovirus in preparations for which no reference standard is available (see below). Also, host nucleic acids were eluted much later than adenovirus (mostly in the sodium hydroxide wash), which made virus quantitation very accurate in samples having very low virus titers as well as samples grossly contaminated by nucleic acids.
This method gave a linear response in the range 2.5 × 
10
7 to 5 × 10 11 particles injected (r, 0.9999) and quite a satisfactory injection repeatability value (RSD, 0.9%; n ϭ 9). The limit of quantitation was 1 × 10 8 viral particles (vp) in crude lysates and was 2.5 × 10 7 vp in purified samples. This is at least 10-fold lower than the limit of quantitation of the method with Source 15Q, which is у 1 × 10 9 vp for crude samples (unpublished data) and at least 1 × 10 8 vp for purified material. 1 For a given amount of particle loaded on to the column (2.0 × 10 10 vp), the peak area was identical (RSD, 5%) for volume injected ranging from 10 to 2000 l. In addition, at least 1000 assays of crude lysates could be performed with the same column without noticeable degradation of column performance.
Identification and quantitation of the adenovirus peak in crude preparations The Q Sepharose XL method was used to identify the viral peak and to assay the particle content of crude lowtiter samples. Figure 2 shows an example of such an analysis. Although very complex in nature, the chromatogram clearly shows the virus peak which can be accu- rately quantitated. The identification of the peak as adenovirus at retention time 18.5 min relied on several methods which included UV spectroscopy (Figure 2 , inset), peak width (no protein peak is as sharp on this adsorbent), co-elution of the presumed virus peak and an adenovirus reference standard (not shown), and SDS-PAGE analysis of the peak fraction after collection (Figure 4 ). In addition, numerous virus amplifications were done at multiplicities of infection (MOIs) calculated from particle concentrations obtained with the method reported here. All of them gave reproducible and consistent results, giving further support to this HPLC method.
Identification and quantitation of recombinant adenovirus obtained from adenoviral genome When 293 or PER.C6 cells were transfected with PacIdigested adenoviral genome cloned into pXL3185, a cytopathic effect (CPE) was readily observed which was indicative of the presence of adenovirus AV 1.0 CMV.lacZ. Adenoviral particles were measured by chromatography at full CPE. At least 7.6 × 10 9 adenoviral particles were generated within 14 days (Table 2 ). Recombinant adenoviral genomes were produced by the EDRAG technology which generates a homogenous population, therefore Gene Therapy plaque purification is not necessary. Subsequent infections were performed at optimized MOI, thus leading to consistent and reproducible results. As can be seen in Table 2 , up to 3.1 × 10 13 vp were produced at the laboratory scale. Viral particles measured at amplication II were assessed by biological methods such as plaque forming units (pfu) and transducing units (tdu). Vp/pfu values of approximately 25, and tdu/pfu values between 0.45 to 0.57 were obtained, which were in agreement with published values (Table 3) . 3, 4 Purification of AV 1.0 CMV.lacZ adenovirus A total of 1.9 × 10 13 vp of AV 1.0 CMV.lacZ adenovirus produced by amplifications in PER.C6 cells (Table 2) , were purified by a single-step anion-exchange chromatography procedure with Q Sepharose XL, yielding 1.4 × 10 13 vp with an overall particle recovery of 74% (Table 4) . No particles were detected in the flow-through (Ͻ1%).
Purification of a fiber-modified AV 1.k CMV.lacZ adenovirus AV 1.k CMV.lacZ adenovirus was generated by transfection of PacI-digested adenoviral genome cloned into pXL3497, followed by three amplifications in PER.C6. Conditions were similar to the conditions previously described for AV 1.0 CMV.lacZ, except that full CPE was delayed. A total of 5.0 × 10 12 vp was purified by the twostep chromatography procedure (Source 15Q-Q Sepharose XL), with an overall particle recovery of 68%. A first chromatography on Source 15Q was introduced as a capture step to clean up the virus from the bulk of contaminants and to concentrate the sample before the second (polishing) chromatography. Again, no particles (Ͻ1%) were detected in the flow-through for both columns.
Production and purification of a third-generation AV 3.0 RSV.GDNF adenovirus IGRP2 cells were transfected with PacI-digested pXL3615, followed by two amplifications in IGRP2 cells to generate AV 3.0 RSV.GDNF, a third generation recombinant adenovirus expressing the simian GDNF. A total of 1.9 × 10 10 vp were obtained at full CPE 16 days after transfection (Table 5 ). Subsequent infections were performed at MOIs of 100 and 80, yielding a total of 1 × 10 13 vp at the laboratory scale (Table 5 ). AV 3.0 RSV.GDNF adenovirus was purified from the pelleted cells by the two-step chromatography procedure, with an overall yield of 50%. Expression of GDNF from AV 3.0 RSV.GDNF (amplification II) was verified by Western analysis (data not shown).
Purity of purified preparations
After purification, AV 1.0 CMV.lacZ, AV 1.k CMV.lacZ, and AV 3.0 RSV.GDNF preparations were homogeneous by IE-HPLC on Source 15Q (Ͼ99.5%). AV 1.k CMV.lacZ, and Table 2 . Aliquots from amplification II were titered by the standard biological assays (pfu and tdu) as described in Materials and methods. After centrifugation and filtration, adenovirus particles were purified by HPLC with a 20-ml Q Sepharose XL column eluted in conditions described in Materials and methods. The virus peak was collected, buffer-exchanged and concentrated through an Ultrafree PF-60 (30 kDa), and 0.2 m filtered before testing. Chromatographic characterization of wild-type adenoviruses Wild-type adenoviruses of different serotypes were amplified in A549 cells and analyzed by chromatography with Q Sepharose XL. In spite of the absence of corresponding reference standard for each serotype, the identification of the virus peak was made possible because of the large difference in peak width between virus and contaminants (proteins and nucleic acids). Table 6 summarizes the chromatographic parameters obtained. Interestingly, the retention time and ratio of absorbance A 260 /A 280 were specific to each serotype and therefore represent one criterion to identify an adenovirus serotype. A correlation was found between the retention time on the HPLC column and the hexon sequence. Table 6 includes the sequence identity data available for hexon proteins and the charge at pH 7.0 of the hexon and of its L1 loop. 6 It can be deduced from these data that the lower the negative charge of the hexon (and more specifically the charge of the L1 loop) the more strongly the adenovirus is retained on the column. Since the L1 loop is both highly Wild-type adenovirus was amplified in A549 cells and harvested 3 days after infection by three freeze-thaw cycles. After centrifugation and filtration (0.2 m), 1 ml of the supernatant was analyzed by HPLC on a 1.3-ml Q Sepharose XL column eluted as described in Materials and methods. The retention time for Ad5 (25.3 min) is longer than that reported in Table 1 (18.5 min) because a slightly more shallow salt gradient was used to elute the column in this particular series of analyses.
negatively charged and one of the most exposed regions of the hexon 7 it is a good candidate for the interaction of adenovirus with the column (see Discussion).
Discussion
HPLC on Source 15Q has been recently introduced as a method of choice to assay adenovirus particles in crude lysates. However, this method is not sensitive enough to assay particles in crude and very dilute preparations and is limited by interferences with host nucleic acids, making this method largely inaccurate unless nucleic acids are digested before the HPLC analysis.
1,2 On the other hand, we have obtained growing evidence that in some production conditions, this enzymatic treatment results in virus precipitation. Therefore, we searched for an alternative chromatography adsorbent which could overcome these limitations. We found that Q Sepharose XL, a commercially available anion-exchange adsorbent proposed for production scale purification of proteins, offers quite dramatic advantages over Source 15Q for the separation of adenovirus. These include a 10-fold more sensitive detection for adenovirus, no interference with host nucleic acid, and much sharper and highly symmetrical virus peak resulting in incomparably easier identification of the virus peak in complex chromatograms obtained from, for example, dilute crude lysates. Furthermore this separation method has been successfully used in a preparative mode to purify viral particles directly from crude lysates.
The reason for the excellent and unprecedented performances of Q Sepharose XL for chromatography of adenovirus has not been fully elucidated as yet. Indeed, the poor performances of this adsorbent for proteins are in line with the broad size distribution (45-165 m) of Q Sepharose XL beads. The extremely high chromatographic efficiency for viral particles indicates that a particular and specific interaction mechanism takes place with
Gene Therapy viral particles. Q Sepharose XL is made up of cross-linked 6% agarose, a chemical composition which is common to Q Sepharose Fast Flow (also 45-165 m). The poor efficiency of this later gel for virus (N/m, 5000) indicates that the chemical composition of the beads is definitely not a key factor for Q Sepharose XL efficiency (Table 1) . Furthermore, the presence of flexible dextran arms on which the exchanger groups are attached is not the main factor responsible for its superior performances since Fractogel TMAE(s), which is a 20-40 m bead size resin whose exchanger groups are located all along flexible arms made up of polyacrylamide extensions named tentacles, exhibits rather modest performances with N/m and As values of 21 500 and 1.5, respectively (Table 1) .
It is likely that the very high chromatographic performance of Q Sepharose XL for adenovirus depends at least partly on the particular spatial arrangement of the strong anion-exchange groups on the flexible arms, on the chemical structure of these arms, and on the pore size distribution of the beads. These factors are likely to favor on/off exchange kinetics within the beads resulting in the unexpected properties observed. Apparently, this effect which is quite specific to virus particles, is probably due to their large size (150 MDa; approximately 100 nm in diameter), 8 which is well above the size of the largest proteins currently chromatographed on these supports for which they have been developed.
Another intriguing question related to the mechanism of interaction between particles and the anion exchanger concerns the identification of the adenoviral functional groups which mediate this interaction. The structure of adenovirus indicates that these functional groups must belong to proteins II, III, IIIa, IV, or IX. 8 The very limited exposure of proteins III and IIIa to the outside environment and the very weak net charge of protein IX at neural pH (−0.23 charge at pH 7.0, Ad5 protein sequence SwissProt P03281) makes these proteins poor candidates for interaction with the adsorbent. In contrast, owing to its protruding structure and its net charge (3.6 negative charges at pH 7.0), the fiber (IV) may be involved in interactions with the chromatography support. The strongest interaction is likely to be mediated by the hexon protein (II) because of its net negative charge (24.8) at pH 7.0 and its high abundance (720 polypeptides per virion). This assumption is supported by the presence of a stretch of acidic residues in the sequence of the Ad2 and Ad5 hexons (position 133 to 161) which is partially exposed on the outer surface of the particle. 7 Interestingly, the interaction with the adsorbent is not mediated by these acidic residues only since Ad3, Ad4 and Ad7 which do not contain this sequence of acidic residues are also retained on this adsorbent (Table 6 ). However, a trend was found between the charge of the hexon L1 loop (which contains the region 133 to 166) and the HPLC retention time (Table 6 ), which indicates that the acidic region of the hexon protein is very likely to be a major determinant of the strong interaction with Q Sepharose XL observed with Ad2 and Ad5.
With this method, the production of first as well as third generation recombinant adenovirus from linear adenoviral genome is conveniently monitored by viral particle measurements at the stage of transfection. This allows for optimization and standardization of the production process at each step, which is highly recommended to comply with current Good Manufacturing Practice. Under optimized conditions, about 3 × 10 8 pfu (7.6 × 10 9 vp) could be obtained within 14 days of transfection of 3 g of linear adenoviral genomic DNA of AV 1.0 CMV.lacZ (Table 2 ). These figures are in the same range as the best values reported by He et al 9 whose measurements could only be made because a green fluorescent protein encoding gene was incorporated into their adenoviral backbone. Similarly, 1.9 × 10 10 vp of AV 3.0 RSV.GDNF could be obtained within 16 days of transfection of 2.9 g of linear adenoviral genomic DNA of AV 3.0 RSV.GDNF (Table 5 ). The HPLC method we describe here is transgene-independent and could become a reference method for the various optimized adenoviral vectors under development. 10 Currently, the most widely accepted method to titer modified adenoviral vectors is a particle quantitation by optical absorbance. 3 Unfortunately, this very simple and reliable method can only be applied to purified preparations. The HPLC method reported here allows for the measurement of viral particles in crude extract of optimized vectors such as viruses with modified fiber or third generation vectors (this paper), or modified hexon vectors. 11 Its use could be extended to the quantitation of adenoviruses produced with low titers such as fiberless recombinant variants 12, 13 or adenoviral vectors gutted of almost the entire adenoviral genome. 14, 15 Materials and methods
Cell culturing
Cultures of IGRP2 4 293 or A549 cells (American Type Culture Collection) were grown in T-150 flask containing modified Eagle's medium (MEM, GibcoBRL, Cergy-Pontoise, France) supplemented with 10% fetal calf serum (FCS, Hyclone, Erembodegem-Aalst, Belgium) in a 5% CO 2 atmosphere at 37°C. 16 Geneticin (GibcoBRL) was added to the medium at a final concentration of 350 g/ml for IGRP2 cells. PER.C6™ cells (Introgene, BV, Leiden, The Netherlands) were also grown in T-150 flasks containing Dulbecco's modified medium (DMEM, GibcoBRL), 10% FCS and 10 mm MgCl 2 in a 10% CO 2 atmosphere at 37°C. 17 
Adenoviral genome
Recombinant adenoviral genomes were cloned into an RK2-derived plasmid by homologous recombinations in E. coli utilizing the EDRAG technology. 18 The technology was simplified by replacing the ColE1 origin of replication by the ori ␥ of R6K in the suicide shuttle 19 which allows recombination in any recA + E. coli strain. Plasmid pXL3185 is 57.6 kbp long and derives from the very stable RK2 vector. It contains an E1,E3-deleted Ad5 genome with an E. coli lacZ gene under the control of the human cytomegalovirus promoter in the E1 deleted region. It leads to the generation of AV 1.0 CMV.lacZ adenovirus. Plasmid pXL3497 derives from pXL3185 and has a sequence inserted at position 32784 (Ad5 coordinates) which corresponds to the addition of a (Gly-Ser) 5 -(Lys) 7 peptide at the C-terminus of the fiber protein. 20 The corresponding adenovirus, AV 1.k CMV.lacZ, was described as AdZ.F(pK7)␤gal by Wickham et al. 20 Plasmid pXL3615 is an RK2-derived vector containing an Ad5 genome carrying deletions in the E1 region (from position 386 to position 3512), in the E3 region (from position 28 592 to position 30 470) and in the E4 region (from position 33 423 to position 35 356). The simian GDNF cDNA 21 under the control of the Rous sarcoma virus promoter was inserted in the deleted E1 region.
The integrity of the constructs was assessed by restriction enzyme mapping and Southern analysis. The regions involved in homologous recombination were verified by sequence analysis.
Production of adenovirus
Transfection of adenoviral genomes in PER.C6 cells was performed in the presence of LipofectAMINE (GibcoBRL) in T25 cm 2 flasks. Briefly, 5 g of PacI-digested DNA plasmid diluted into H 2 O were mixed with 23 l of LipofectAMINE. After gentle mixing, the suspension was incubated for 30 min at room temperature. In the meantime, the cells at 50-60% confluence were washed twice with phosphate buffered saline which was then replaced by the LipofectAMINE/DNA mixture to which 3.8 ml of serum-free DMEM were added. The cells were incubated at 37°C for 5 to 8 h, after which the medium was replaced by DMEM containing 10% fetal calf serum and 10 mm MgCl 2 . Three days after transfection the cells were split into one T75 cm 2 flask. Cells and supernatant were harvested at full CPE (day [10] [11] [12] [13] [14] and freeze/thawed for three cycles followed by centrifugation and collection of the supernatant. A similar protocol with MEM was used for 293 cells. For IGRP2 cells, the transfection mixture was incubated for 7 h after which the spent medium was removed and replaced with MEM containing 10% fetal calf serum plus dexamethasone at a final concentration of 10 −8 m. At day 2, the transfection was split and at day 5 the medium was removed and replaced with fresh MEM containing 10% fetal calf serum plus dexamethasone at a final concentration of 10 −8 m. PER.C6, IGRP2 or 293 cells were infected at a confluence of approximately 70% with recombinant adenovirus at an MOI between 30 to 100 viral particles per cell in T150 cm 2 flasks. The medium for IGRP2 cells also contained dexamethasone at a final concentration of 10 −8 m. At full CPE cells and supernatant were harvested, freeze/thawed for three cycles, centrifuged and the supernatants collected and pooled (AV 1.0 CMV.lacZ and AV 1.k CMV.lacZ) or processed separately (AV 3.0 RSV.GDNF). Wild-type adenoviruses were produced in A549 cells under similar conditions. Ad5CMV.p53 22 was produced and purified as previously described (patent application WO 98/00524).
Biological assays
Adenovirus preparations were assayed on 293 monolayers as pfu. 16 They were also titrated on W162 monolayers as lacZ-transducing units. 4 Analytical chromatography HPLC separations were performed utilizing a Waters quaternary LC 626 system equipped with a 717plus Autosampler refrigerated at +8°C and a 996 Photodiode Array Detector (set at 220 to 350 nm). The mobile phases were buffer A, 20 mm Tris/HCl, pH 7.5; and buffer B, 1 m NaCl in buffer A. Separations were carried out at 20°C at a flow rate of 1.5 ml/min on a HR 5/5 column (Amersham Pharmacia Biotech, Uppsala, Sweden) packed with 1 ml of Q Sepharose XL adsorbent (Amersham Pharmacia Biotech). The column was equilibrated with buffer A, and after sample loading (0.1 to 2.0 ml), elution was carried out with 4.5 column volumes (CV) of buffer A followed by a 0 to 70% linear gradient of buffer B over 25.5 CV, 70% buffer B over 1.5 CV, and a second gradient of 70% to 100% buffer B over 3 CV. All samples to be assayed were 0.45 m filtered before chromatography. Standard curves were constructed by injecting increasing amounts of a chromatographically purified reference standard (5 × 10 8 to 5 × 10 11 total particles injected). The number of total viral particles in this standard was obtained spectrophotometrically using the conversion factor of 1.1 × 10 12 particles per absorbance unit at 260 nm. 23 After each analytical run, the column was cleaned by eluting with 1.5 CV of 0.5 N sodium hydroxide.
Analytical separations on other chromatography supports were carried out similarly on HR 5/5 columns packed with 1 ml of the corresponding adsorbent. Height Equivalent to a Theoretical Plate (HETP) values at 50% peak height and asymmetry (As) values at 10% peak height were calculated automatically with Suitability (Waters, Milford, MA, USA) from the analysis of 2.0 × 10 10 purified particles or 100 g of bovine serum albumin (Sigma, St Louis, MO, USA). Column efficiencies were expressed as N/m, the number of theoretical plates per linear meter of column.
Purification of adenovirus AV 1.k CMV.lacZ was amplified in PER.C6 cells and harvested at full CPE. The filtered crude lysate was loaded on to a HR 10/10 column packed with 8 ml of Source 15Q (Amersham Pharmacia Biotech), previously equilibrated with 20 mm Tris/HCl, pH 8.0, 1 mm MgCl 2 , 0.25 m NaCl. After washing the column with five column volumes of equilibration buffer, adenovirus particles were eluted at a flow rate of 3 ml/min with a linear gradient of 0.25 m to 1 m NaCl. The virus peak (10 ml) was collected, diluted with one volume of 20 mm Tris/HCl buffer and chromatographed on a 7.5-ml HR 10/10 column of Q Sepharose Gene Therapy XL. After washing the column with 0.25 m NaCl in 20 mm Tris/HCl, pH 8.0, 1 mm MgCl 2 , adenovirus particles were eluted with a linear gradient of NaCl (0.25 to 1.0 m) in buffer A over 30 column volumes. The virus peak was collected, buffer exchanged by gel filtration on Sephadex G-25 PD-10 columns (Amersham Pharmacia Biotech), concentrated to 3.0 × 10 12 viral particles per ml by ultrafiltration with an Ultrafree 15-100 kDa centrifugation device (Millipore, Bedford, MA, USA), sterile filtered through a 0.2 m Millex filter (Millipore), and stored at −20°C until use. AV 3.0 RSV.GDNF was purified following the same procedure. AV 1.0 CMV.lacZ was purified similarly except that the first chromatography on Source 15Q was omitted.
